Mint Solutions, developer of the medication safety system MedEye, just announced a €5m Series B round led by Brabant Development Partners and LSP (Life Sciences Partners), and Seventure Partners. Other shareholders, including Icelandic NSA Ventures, and smaller private shareholders, also participated in the round.
“This investment comes at a crucial time for our MedEye product,” Gauti Reynisson, CEO of Mint Solutions said in a written statement. “We are experiencing strong demand from Dutch hospitals and we see ample growth opportunity in other care segments, including long-term care, as well as international markets.”
Mint Solutions is an Dutch-Icelandic company that was established to improve medication safety. It’s main product, MedEye, uses computer vision to ensure that patients get the right medication, in the right dosage, at the right time.